International Stem Cell (ISCO) Receivables - Net (2010 - 2026)
International Stem Cell (ISCO) recorded Receivables - Net of $959,000 in Q2 2026, down 12.9% from $1.1 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell reported Receivables - Net of $723,000, down 31.7% from FY2024.
- Annual Receivables - Net has a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Net came in at $1.06 million in FY2024 (+84.3%), $574,000 in FY2023 (-23.2%), $747,000 in FY2022 (-11.5%) and $844,000 in FY2021 (+109.4%).
- Quarterly Receivables - Net has ranged from $427,000 in Q3 2022 to $1.1 million in Q2 2025 over the past five years.
- On a year-over-year basis, Receivables - Net rose in five of the last seven quarters, with growth averaging 23.6%.
- Peak year-over-year performance for Receivables - Net in the last five years was growth of 109.4% in Q4 2021, against a decline of 36.1% in Q3 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.67 Bn | 1,100.26 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 614.28 Bn | 532.81 Bn | 17.26 Bn |
| 3 | AbbVie | 503.23 Bn | 476.34 Bn | 12.70 Bn |
| 4 | Merck | 368.28 Bn | 322.66 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.22 Bn | 262.21 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn |
| 7 | Amgen | 235.92 Bn | 191.31 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.78 Bn | 164.98 Bn | 6.22 Bn |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn |
| 10 | International Stem Cell | 1.68 Mn | -2.29 Mn | 1.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 959,000.00 |
| Dec 31, 2025 | 723,000.00 |
| Sep 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 851,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 680,000.00 |
| Jun 30, 2024 | 810,000.00 |
| Mar 31, 2024 | 632,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 644,000.00 |
| Jun 30, 2023 | 662,000.00 |
| Mar 31, 2023 | 688,000.00 |
| Dec 31, 2022 | 747,000.00 |
| Sep 30, 2022 | 427,000.00 |
| Jun 30, 2022 | 663,000.00 |
| Mar 31, 2022 | 902,000.00 |
| Dec 31, 2021 | 844,000.00 |
| Sep 30, 2021 | 668,000.00 |
| Jun 30, 2021 | 547,000.00 |
API Access
International Stem Cell Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();